Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesStefano Ugel, Vincenzo Bronte|Journal of Clinical Investigation|2015Cited by 554
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockadeNicolas Jacquelot, Laurence Zitvogel, Gautier Stoll et al.|Cell Research|2019Cited by 246
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3Rosalinda Trovato, Stefano Ugel|Journal for ImmunoTherapy of Cancer|2019Cited by 187
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapySara Sandri, Stefano Ugel|Oncotarget|2017Cited by 29
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axisChiara Musiu, Stefano Ugel|Cell Death and Differentiation|2021Cited by 22